Key facts
- Jianhu Medical’s last known valuation is $94.1M (Jul 2025).
- It has raised $20.9M; the latest was Early Stage VC ($20.9M) in Jul 2025.
- Notable investors include Kunshan Industrial Technology Research Institute, Lifetech Scientific, Realharmony Capital, Shanghai Creation Investment Management.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Jianhu Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Jianhu Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jianhu Medical
Provider of cardiac interventional ablation surgical solutions intended for the field of cardiac electrophysiology. The company focuses on innovative interventional imaging technologies and creates complete cardiac electrophysiology solutions through the integrated strategy of imaging platform, energy platform and consumables, providing clients with innovative cardiac electrophysiological diagnosis and treatment technology.
- Sector
- Healthcare
- HQ
- Kunshan, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Jianhu Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jianhu Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jianhu Medical in its N-PORT filings yet. We sweep new filings monthly.